Focusing on quality patient care in the new global subsidy for malaria medicines.
AffiliationGiorgio Ruffolo Doctoral Research Fellow, Sustainability Science Program, Center for International Development, Kennedy School of Government, Harvard University, Cambridge, Massachusetts, USA.
MetadataShow full item record
AbstractTido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on quality patient care.
- Why the world needs another malaria initiative.
- Issue date: 2004 Jul 31-Aug 6
- Universal access to malaria medicines: innovation in financing and delivery.
- Authors: Adeyi O, Atun R
- Issue date: 2010 Nov 27
- Implementation of the Affordable Medicines for Malaria Facility (AMFm) in Ghana: processes, challenges and achievements.
- Authors: Malm KL, Segbaya S, Forson I, Gakpey KD, Sampong LB, Adjei EA, Bart-Plange C
- Issue date: 2013 May
- Qinghaosu (artemisinin): the price of success.
- Authors: White NJ
- Issue date: 2008 Apr 18
- The Affordable Medicines Facility-malaria--a success in peril.
- Authors: Talisuna AO, Adibaku S, Amojah CN, Amofah GK, Aubyn V, Dodoo A, Juma E, Jackou DH, Mkude S, Okui AP, Ramarosandratana B, Shija SJ
- Issue date: 2012 Nov 8